Koyfin Home > Directory > Health Care > Abeona Therapeutics > EBITDA / Interest Expenses

Abeona Therapeutics EBITDA / Interest Expenses Chart (ABEO)

Abeona Therapeutics annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Abeona Therapeutics EBITDA / Interest Expenses for the quarter ending June 06, 2020 was $-14m a -59,707.47% increase of 8,296m year over year
  • Abeona Therapeutics EBITDA / Interest Expenses for the last 12 months ending June 06, 2020 was $-29m a -118,691.07% increase of 34,739m year over year
  • Abeona Therapeutics Annual EBITDA / Interest Expenses for 2019 was $-168m a -2,918.68% increase of 4,905m from 2018
  • Abeona Therapeutics Annual EBITDA / Interest Expenses for 2018 was $-5,073m a 33.24% decrease of -1,686m from 2017
  • Abeona Therapeutics Annual EBITDA / Interest Expenses for 2017 was $-3,387m a -13.46% increase of 456m from 2016
Other Ratios Metrics:
  • Abeona Therapeutics Total Debt / Capital for the quarter ending December 12, 2014 was $8m a -1,061.80% decrease of -81m year over year
  • Abeona Therapeutics Other Liabilities for the quarter ending December 12, 2017 was $3m a -14.77% decrease of 0m year over year
  • Abeona Therapeutics Total Debt / Equity for the quarter ending December 12, 2014 was $8m a -36,027.59% decrease of -2,992m year over year
View Chart On Koyfin

Quarterly ABEO EBITDA / Interest Expenses Data

06/2020$-14m
03/2020$-21m
12/2019$-35m
12/2018$-8,310m
09/2018$-5,470m
06/2018$-4,089m
03/2018$-3,503m
12/2017$-8,604m
09/2017$-2,612m
06/2017$-2,744m

Annual ABEO EBITDA / Interest Expenses Data

2019$-168m
2018$-5,073m
2017$-3,387m
2016$-3,843m
2015$-2,999m
2014$-5m
2013$-14m
2012$-6m
2010$-12m